Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1.16% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
NAGE · Jun 30, 2024
Niagen Bioscience, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-24-035591General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
11.89% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
50.62% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
60.22% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-1.13% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.79% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
5.21% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History17 statesSelf-history eligible
Jun 30, 20220/6 normalizedLevel 3Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/6 normalizedLevel 3Mar 31, 20230/6 normalizedLevel 3Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20246/7 normalizedLevel 3Sep 30, 20246/7 normalizedLevel 3Dec 31, 20246/7 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20257/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 1.33%
- Current
- -1.16%
- Delta
- -2.49%
- Previous
- -1.79%
- Current
- 11.89%
- Delta
- 13.67%
- Previous
- 56.40%
- Current
- 50.62%
- Delta
- -5.78%
- Previous
- 60.74%
- Current
- 60.22%
- Delta
- -0.52%
- Previous
- -3.30%
- Current
- -1.13%
- Delta
- 2.17%
- Previous
- 9.46%
- Current
- 5.79%
- Delta
- -3.67%
- Previous
- 4.44%
- Current
- 5.21%
- Delta
- 0.77%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · NAGE Fundamental State →Analogous To · NAGE state analogue 3 →Has State · Niagen Bioscience, Inc. →Transitioned To · NAGE Fundamental State →Transitioned To · NAGE CASH_GENERATION_DECREASED →Transitioned To · NAGE GROWTH_INCREASED →Transitioned To · NAGE INVENTORY_PRESSURE_DECREASED →Transitioned To · NAGE MARGIN_DECREASED →Transitioned To · NAGE PROFITABILITY_INCREASED →Transitioned To · NAGE R_AND_D_INTENSITY_DECREASED →Transitioned To · NAGE SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.